2025年第四季度，Encompass Health的盈利预期超出预期，并上调了2026年的财报指引，股价上涨17.5%。 Encompass Health beat earnings estimates in Q4 2025 and raised 2026 guidance, boosting its stock 17.5%.

Encompass Health公司报告说,2025年第四季度的收入为每股1.46美元,超过估计,收入为15.4亿美元,比上一年增加9.9%。 Encompass Health reported fourth-quarter 2025 earnings of $1.46 per share, exceeding estimates, on $1.54 billion in revenue, a 9.9% year-over-year increase. 该公司将2026年的收入指导提高到每股5.81-6.10美元,预计收入为6.37-6.47亿美元。 The company raised its 2026 earnings guidance to $5.81–$6.10 per share and projected revenue of $6.37–$6.47 billion. 经调整的EBITDA和运营利润率上升,自由现金流改善。 Adjusted EBITDA and operating margins rose, and free cash flow improved. 由于康复服务业的强表现和稳定的财务增长, 股票在结果后升了17.5%. The stock surged 17.5% following the results, driven by strong performance in rehabilitation services and consistent financial growth.